MDLN

Medline
D

MDLN

Arincen64/100B

Medline operating income 2022–2026

Medline's operating income in Q3 FY2026, the three months to 26 September 2026, was 500.00M USD, down 12.9% on the same quarter a year before. Medline's operating income in fiscal year 2025 was 2.21B USD, up 3.1% on the year before.

Last updated 9 Nov 2026 · Next report 24 Feb 2027

Operating income

Operating income · +36.5% a year over 3 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM26 Sept 20261.74B—5.68%7.72B25.16%2.57B
FY202531 Dec 20252.21B+3.08%7.78%7.52B26.44%2.26B
FY202431 Dec 20242.15B+71.68%8.41%6.29B24.66%3.53B
FY202331 Dec 20231.25B+43.68%5.38%5.22B22.48%2.59B
FY202231 Dec 2022870.00M—4.06%4.56B21.25%1.85B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Income statement

Common questions about Medline's operating income

Source: Financial Modeling Prep